252 related articles for article (PubMed ID: 31724824)
1. PRC2-complex related dysfunction in overgrowth syndromes: A review of EZH2, EED, and SUZ12 and their syndromic phenotypes.
Cyrus S; Burkardt D; Weaver DD; Gibson WT
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):519-531. PubMed ID: 31724824
[TBL] [Abstract][Full Text] [Related]
2. EED related overgrowth: First report of multiple members in a single family.
Goel H; O'Donnell S; Edwards M
Am J Med Genet A; 2024 Feb; 194(2):374-382. PubMed ID: 37840385
[TBL] [Abstract][Full Text] [Related]
3. Mutations in genes encoding polycomb repressive complex 2 subunits cause Weaver syndrome.
Imagawa E; Higashimoto K; Sakai Y; Numakura C; Okamoto N; Matsunaga S; Ryo A; Sato Y; Sanefuji M; Ihara K; Takada Y; Nishimura G; Saitsu H; Mizuguchi T; Miyatake S; Nakashima M; Miyake N; Soejima H; Matsumoto N
Hum Mutat; 2017 Jun; 38(6):637-648. PubMed ID: 28229514
[TBL] [Abstract][Full Text] [Related]
4. EED and EZH2 constitutive variants: A study to expand the Cohen-Gibson syndrome phenotype and contrast it with Weaver syndrome.
Griffiths S; Loveday C; Zachariou A; Behan LA; Chandler K; Cole T; D'Arrigo S; Dieckmann A; Foster A; Gibney J; Hunter M; Milani D; Pantaleoni C; Roche E; Sherlock M; Springer A; White SM; ; Tatton-Brown K
Am J Med Genet A; 2019 Apr; 179(4):588-594. PubMed ID: 30793471
[TBL] [Abstract][Full Text] [Related]
5. Rare SUZ12 variants commonly cause an overgrowth phenotype.
Cyrus SS; Cohen ASA; Agbahovbe R; Avela K; Yeung KS; Chung BHY; Luk HM; Tkachenko N; Choufani S; Weksberg R; Lopez-Rangel E; ; Brown K; Saenz MS; Svihovec S; McCandless SE; Bird LM; Garcia AG; Gambello MJ; McWalter K; Schnur RE; An J; Jones SJM; Bhalla SK; Pinz H; Braddock SR; Gibson WT
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):532-547. PubMed ID: 31736240
[TBL] [Abstract][Full Text] [Related]
6. DNA Methylation Signature for EZH2 Functionally Classifies Sequence Variants in Three PRC2 Complex Genes.
Choufani S; Gibson WT; Turinsky AL; Chung BHY; Wang T; Garg K; Vitriolo A; Cohen ASA; Cyrus S; Goodman S; Chater-Diehl E; Brzezinski J; Brudno M; Ming LH; White SM; Lynch SA; Clericuzio C; Temple IK; Flinter F; McConnell V; Cushing T; Bird LM; Splitt M; Kerr B; Scherer SW; Machado J; Imagawa E; Okamoto N; Matsumoto N; Testa G; Iascone M; Tenconi R; Caluseriu O; Mendoza-Londono R; Chitayat D; Cytrynbaum C; Tatton-Brown K; Weksberg R
Am J Hum Genet; 2020 May; 106(5):596-610. PubMed ID: 32243864
[TBL] [Abstract][Full Text] [Related]
7. Loss of maternal EED results in postnatal overgrowth.
Prokopuk L; Stringer JM; White CR; Vossen RHAM; White SJ; Cohen ASA; Gibson WT; Western PS
Clin Epigenetics; 2018 Jul; 10(1):95. PubMed ID: 30005706
[TBL] [Abstract][Full Text] [Related]
8. Imagawa-Matsumoto syndrome: SUZ12-related overgrowth disorder.
Imagawa E; Seyama R; Aoi H; Uchiyama Y; Marcarini BG; Furquim I; Honjo RS; Bertola DR; Kim CA; Matsumoto N
Clin Genet; 2023 Apr; 103(4):383-391. PubMed ID: 36645289
[TBL] [Abstract][Full Text] [Related]
9. Biallelic loss-of-function variants of EZH1 cause a novel developmental disorder with central precocious puberty.
Okamoto N; Yoshida S; Ogitani A; Etani Y; Yanagi K; Kaname T
Am J Med Genet A; 2024 May; ():e63726. PubMed ID: 38814056
[TBL] [Abstract][Full Text] [Related]
10. Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro.
Cohen AS; Yap DB; Lewis ME; Chijiwa C; Ramos-Arroyo MA; Tkachenko N; Milano V; Fradin M; McKinnon ML; Townsend KN; Xu J; Van Allen MI; Ross CJ; Dobyns WB; Weaver DD; Gibson WT
Hum Mutat; 2016 Mar; 37(3):301-7. PubMed ID: 26694085
[TBL] [Abstract][Full Text] [Related]
11. Ezh2 Mutations Found in the Weaver Overgrowth Syndrome Cause a Partial Loss of H3K27 Histone Methyltransferase Activity.
Lui JC; Barnes KM; Dong L; Yue S; Graber E; Rapaport R; Dauber A; Nilsson O; Baron J
J Clin Endocrinol Metab; 2018 Apr; 103(4):1470-1478. PubMed ID: 29244146
[TBL] [Abstract][Full Text] [Related]
12. Manifestation of epilepsy in a patient with EED-related overgrowth (Cohen-Gibson syndrome).
Hetzelt KLML; Winterholler M; Kerling F; Rauch C; Ekici AB; Winterpacht A; Vasileiou G; Uebe S; Thiel CT; Kraus C; Reis A; Zweier C
Am J Med Genet A; 2022 Jan; 188(1):292-297. PubMed ID: 34533271
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
[TBL] [Abstract][Full Text] [Related]
14. Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype.
Tatton-Brown K; Murray A; Hanks S; Douglas J; Armstrong R; Banka S; Bird LM; Clericuzio CL; Cormier-Daire V; Cushing T; Flinter F; Jacquemont ML; Joss S; Kinning E; Lynch SA; Magee A; McConnell V; Medeira A; Ozono K; Patton M; Rankin J; Shears D; Simon M; Splitt M; Strenger V; Stuurman K; Taylor C; Titheradge H; Van Maldergem L; Temple IK; Cole T; Seal S; ; Rahman N
Am J Med Genet A; 2013 Dec; 161A(12):2972-80. PubMed ID: 24214728
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma.
Wasenang W; Puapairoj A; Settasatian C; Proungvitaya S; Limpaiboon T
Pathol Res Pract; 2019 Jul; 215(7):152451. PubMed ID: 31126817
[TBL] [Abstract][Full Text] [Related]
16. EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia.
Schäfer V; Ernst J; Rinke J; Winkelmann N; Beck JF; Hochhaus A; Gruhn B; Ernst T
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1641-50. PubMed ID: 27169594
[TBL] [Abstract][Full Text] [Related]
17. Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs.
Zhao Y; Guan YY; Zhao F; Yu T; Zhang SJ; Zhang YZ; Duan YC; Zhou XL
Eur J Med Chem; 2022 Mar; 231():114144. PubMed ID: 35093670
[TBL] [Abstract][Full Text] [Related]
18. Novel SUZ12 mutations in Weaver-like syndrome.
Imagawa E; Albuquerque EVA; Isidor B; Mitsuhashi S; Mizuguchi T; Miyatake S; Takata A; Miyake N; Boguszewski MCS; Boguszewski CL; Lerario AM; Funari MA; Jorge AAL; Matsumoto N
Clin Genet; 2018 Nov; 94(5):461-466. PubMed ID: 30019515
[TBL] [Abstract][Full Text] [Related]
19. Three additional patients with EED-associated overgrowth: potential mutation hotspots identified?
Spellicy CJ; Peng Y; Olewiler L; Cathey SS; Rogers RC; Bartholomew D; Johnson J; Alexov E; Lee JA; Friez MJ; Jones JR
J Hum Genet; 2019 Jun; 64(6):561-572. PubMed ID: 30858506
[TBL] [Abstract][Full Text] [Related]
20. Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside.
Korfhage J; Lombard DB
Mol Cancer Res; 2019 Jul; 17(7):1417-1428. PubMed ID: 31023785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
